Overview

MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED)

Status:
Completed
Trial end date:
2009-04-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy and safety of an investigational treatment for type 2 diabetes mellitus.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Metformin
Sitagliptin Phosphate